Article Details

Myriad Genetics (MYGN) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2019-01-15 19:48:45

Tags for this article:

Click the tags to see associated articles and topics

Myriad Genetics (MYGN) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC lifted its holdings in Myriad Genetics by 2.6% during the 3rd quarter. <b>Acadian Asset Management</b> LLC now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo